Global Liver Disease Diagnostics Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2029
“Global Liver Disease Diagnostics Market” is the title of an upcoming report offered by MarketResearch.Biz. The report contains information and data, and inputs from both primary and secondary data sources, that have been verified and validated by experts in the target market. The report presents a thorough study of revenues, historical data, and information, key developments, and strategies by major players that offer vital insights and perspectives in various scenarios market. Besides critical data and related information, the report includes key trends (both present and future), factors that are driving market growth, factors that are or could be potential restraints to market growth, as well as opportunities that can be leveraged for potential revenue generation in untapped regions and countries. It also covers threats or challenges for existing as well as new entrants in the market. The global liver disease diagnostics market has been segmented on the basis of diagnosis technique, end-use, as well as regions and countries.
A group of blood tests called liver function tests are used to diagnose chronic and acute liver diseases. Various other blood tests can be undertaken to determine a specific liver disorder, or a pre-existing genetic condition. An MRI scan, ultrasound and CT scan are imaging tests that can be done to show liver damage.
The increasing prevalence of chronic and acute liver diseases is one of the primary factors that is expected to fuel revenue growth of the global liver disease diagnostics market in the years to come. Increasing research & development being undertaken by key industry players towards the development of precise diagnostic systems to improve early diagnosis and patient treatment results are also slated to boost revenue growth of this global market in the future.
Additionally, the introduction of novel approaches to diagnose liver diseases is expected to positively contribute to the future market growth. Furthermore, favorable reimbursement policies under various health insurance programs that are offered by respective governing bodies are expected to fuel revenue growth of the global liver disease diagnostics market in the foreseeable future.
Segmentation of the global liver disease diagnostics market is as follows:
In terms of diagnosis, the imaging segment accounted for the majority revenue shares of the global liver disease diagnostics market in 2019. This can be attributed to the increasing number of initiatives being carried out by key industry players to innovate advanced imaging techniques. This segment is also expected to register the highest rate of revenue growth over the next 10 years.
On the basis of end-use, the hospitals segment accounted for the highest number of revenue shares of the global liver disease diagnostics market in 2019, owing to the large portion of patients that rely on hospitals that are equipped with diagnostic testing services. Additionally, the continual development of global healthcare infrastructure is expected to enhance existing facilities, thereby, contributing to potential future revenue growth of the global liver disease diagnostics market. The laboratories segment is expected to be the fastest growing segment in the liver disease diagnostics market in the years to come.
Regional Segmentation and Analysis:
North America accounted for the majority revenue share of the global liver disease diagnostics market in 2019, followed by the markets in Europe. This can be accredited to the large presence of key industry players in these regions and increasing investments towards R&D initiatives.
The markets in the APAC region are expected to register substantial revenue growth in the coming years due to the increasing awareness concerning liver diseases and a steadily booming geriatric population.
Segmentation of the Global Liver Disease Diagnostics Market:
Segmentation by Diagnosis Technique:
- Laboratory tests
Segmentation by End-Use:
Segmentation by Region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2020 Estimated Year 2021 Forecast Period 2021–2030 Revenue in US$
- F. Hoffmann-La Roche Ltd.
- Thermo-Fisher Scientific Inc.
- Randox Laboratories Ltd.
- Boston Scientific Corporation
- Laboratory Corporation of America Holdings
- Fujifilm Corporation
- Horiba Medical
- Siemens Healthcare GmbH.
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!